日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Incidental Bladder Lesions on Prostate Multiparametric MRI: Prevalence and Factors Associated with Bladder Carcinoma

前列腺多参数磁共振成像中偶然发现的膀胱病变：患病率及与膀胱癌相关的因素

期刊:Academic Radiology
影响因子:3.9
doi:10.1016/j.acra.2025.10.021
Dogra, Siddhant; Lee, Joshua; Siriruchatanon, Mutita; Gu, Zehui; Huang, Chenchan; Jalal, Hawre; Sereda, Yuliia; Lenis, Andrew; Trikalinos, Thomas A; Kang, Stella K
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma

B7-H3 和 GD2 过表达作为视网膜母细胞瘤的免疫治疗靶点

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-34331-6
Sujjitjoon, Jatuporn; Ng, Wei Loon; Kongkla, Katesara; Jarutatsanangkoon, Kridtin; Chongsutakawewong, Krittiya; Subhadhirasakul, Subongkoch; Uiprasertkul, Mongkol; Udompunturak, Suthipol; Junking, Mutita; Yenchitsomanus, Pa-Thai; Atchaneeyasakul, La-Ongsri
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical Features Associated With Malignant Transformation of Low-Grade Dysplasia

低级别异型增生恶性转化的临床特征

期刊:Journal of Oral Pathology & Medicine
影响因子:2.3
doi:10.1111/jop.70070
Laronde, Denise M; Berkowitz, Matt; Kerr, A Ross; Hade, Erinn M; Siriruchatanon, Mutita; Rosin, Miriam P; Kang, Stella K
发表日期：2026
文献求助 收藏

Understanding Bladder Cancer Screening Limits Through Comparative Modeling: The Maximum Clinical Incidence Reduction (MCLIR) Methodology

通过比较模型了解膀胱癌筛查的局限性：最大临床发病率降低（MCLIR）方法

期刊:
影响因子:
doi:10.64898/2026.01.27.26344939
Jalal, Hawre; Kang, Stella K; Alarid-Escudero, Fernando; Chrysanthopoulou, Stavroula A; Garibay-Trevino, David Ulises; Jacobs, Bruce L; Kuntz, Karen M; Kumar, Praveen; Popp, Jonah H; Sereda, Yuliia; Siriruchatanon, Mutita; Wong, John B; Trikalinos, Thomas A
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

Bladder Cancer Burden in the USA: Population Scenarios for 2040

美国膀胱癌负担：2040 年人口情景

期刊:European Urology Open Science
影响因子:
doi:10.1016/j.euros.2025.11.013
Jalal, Hawre; Kang, Stella K; Alarid-Escudero, Fernando; Chrysanthopoulou, Stavroula A; Garibay-Trevino, David Ulises; Jacobs, Bruce L; Kuntz, Karen M; Kumar, Praveen; Popp, Jonah H; Sereda, Yuliia; Siriruchatanon, Mutita; Wong, John B; Trikalinos, Thomas A
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv.

第五代嵌合抗原受体T细胞靶向整合素αvβ6并分泌抗PD-L1 scFv，增强对胆管癌的细胞毒性

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06453-y
Phanthaphol Nattaporn, Somboonpatarakun Chalermchai, Suwanchiwasiri Kwanpirom, Yuti Pornpimon, Sujjitjoon Jatuporn, Augsornworawat Punn, Baillie George S, Junking Mutita, Yenchitsomanus Pa-Thai
细胞生物学
T细胞
发表日期：2025
文献求助 收藏

Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach

分泌 αB7-H3-αCD3 双特异性接合体的工程 T 细胞可增强对 B7-H3 阳性多发性骨髓瘤的抗肿瘤活性：一种新颖的治疗方法

期刊:Journal of Translational Medicine
影响因子:6.1
doi:10.1186/s12967-024-05923-z
Punchita Rujirachaivej #, Teerapong Siriboonpiputtana #, Kornkan Choomee, Kamonlapat Supimon, Thanich Sangsuwannukul, Pucharee Songprakhon, Krissada Natungnuy, Piriya Luangwattananun, Pornpimon Yuti, Mutita Junking, Pa-Thai Yenchitsomanus
肿瘤
骨髓瘤
T细胞
CD276
发表日期：2025
文献求助 收藏

Cannabidiol sensitizes triple-negative breast cancer cells to NK cell-mediated killing via EGFR inhibition and FAS upregulation

大麻二酚通过抑制EGFR和上调FAS，使三阴性乳腺癌细胞对NK细胞介导的杀伤作用更加敏感。

期刊:Journal of Cannabis Research
影响因子:4.3
doi:10.1186/s42238-025-00340-5
Garunyapakun, Perawat; Ramwarungkura, Boonyanuch; Natungnuy, Krissada; Turbpaiboon, Chairat; Yenchitsomanus, Pa-Thai; Junking, Mutita
肿瘤
肿瘤免疫
EGF
乳腺癌
EGFR
FAS
细胞生物学
发表日期：2025
文献求助 收藏

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial

在一项随机对照试验中，左氧氟沙星用于预防接受 CHOP 联合利妥昔单抗治疗的非霍奇金淋巴瘤患者的发热发作

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-23569-9
Surakijboworn, Mutita; Polprasert, Chantana; Wudhikarn, Kitsada; Rojnuckarin, Ponlapat; Uaprasert, Noppacharn
淋巴瘤
CHOP
HOP
发表日期：2025
文献求助 收藏

Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells

作者更正：吉西他滨联合PD-L1×CD3双特异性T细胞衔接器（BiTE）可增强T淋巴细胞对胆管癌细胞的细胞毒性。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-88644-7
Wathikthinnakon, Methi; Luangwattananun, Piriya; Sawasdee, Nunghathai; Chiawpanit, Chutipa; Lee, Vannajan Sanghiran; Nimmanpipug, Piyarat; Tragoolpua, Yingmanee; Rotarayanont, Siriphorn; Sangsuwannukul, Thanich; Phanthaphol, Nattaporn; Wutti-In, Yupanun; Somboonpatarakun, Chalermchai; Chieochansin, Thaweesak; Junking, Mutita; Sujjitjoon, Jatuporn; Yenchitsomanus, Pa-Thai; Panya, Aussara
肿瘤
T细胞
肿瘤免疫
PD-L1
CD3
T细胞
胆管癌
细胞生物学
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏